Genetic dyslipidemias.

Area of Science:

• Genetics
• Metabolic Disorders
• Cardiovascular Health

Background:

• Genetic factors significantly influence lipid metabolism.
• Genetic dyslipidemias are monogenic defects affecting lipid metabolism proteins.
• Examples include familial hypercholesterolemia (FH) and familial chylomicronemia syndrome (FCS).

Purpose of the Study:

• To summarize the genetic basis and clinical implications of various genetic dyslipidemias.
• To highlight the distinct clinical presentations and risks associated with different genetic lipid disorders.

Main Methods:

• Review of genetic defects and their impact on lipid metabolism.
• Description of clinical phenotypes associated with specific genetic dyslipidemias.

Main Results:

• FH, caused by mutations in LDL receptor pathway genes, leads to severe hypercholesterolemia and premature coronary artery disease.
• FCS, due to mutations in lipoprotein lipase or its cofactors, causes severe hypertriglyceridemia and acute pancreatitis risk.
• Other genetic dyslipidemias include familial partial lipodystrophy, abetalipoproteinemia, and hypoalphalipoproteinemias.

Conclusions:

• Genetic dyslipidemias represent a spectrum of inherited disorders with significant health consequences.
• Accurate diagnosis and understanding of these conditions are crucial for managing cardiovascular and metabolic risks.